Latest news
Amgen (AMGN) Is Up 6.7% After EMA Backs Broader Repatha Use in High-Risk Patients – Has The Bull Case Changed? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 11:46:03 GMTGadsden County plans expanded Havana library with $2M state grant, broader use envisioned - wtwcfoxwtwcfox · Thu, 06 Aug 2026 01:14:05 GMTFresh mBridge progress boosts cross-border digital yuan push - South China Morning PostSouth China Morning Post · Tue, 04 Aug 2026 08:00:09 GMTAmgen’s Repatha receives positive CHMP opinion for broader cardiovascular use - Pharmaceutical Business review -Pharmaceutical Business review - · Thu, 30 Jul 2026 14:31:43 GMTUnderwriting remains insurers’ top AI use case despite broader adoption - Insurance TimesInsurance Times · Wed, 29 Jul 2026 14:04:36 GMTPOSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE - AmgenAmgen · Wed, 29 Jul 2026 07:00:00 GMTAmgen (AMGN) Wins Backing In Europe For Broader Repatha Use - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTThree Cancer Drugs Advance Toward Broader EU Use - MedscapeMedscape · Tue, 28 Jul 2026 07:00:00 GMT